Sysmex, Danaher Settle Blood-Analyzer Patents Suit Before Trial

Oct. 17, 2022, 4:26 PM UTC

Sysmex Corp. and Danaher Corp.’s Beckman Coulter Inc. have settled a patent-infringement suit over blood-sample analyzers less than three weeks before a jury trial had been set to begin, a court filing shows.

No details of the agreement were included in a joint request for dismissal with prejudice filed Friday in the US District Court for the District of Delaware. The court hasn’t yet approved the pact, which would dimiss Sysmex’s claims and Beckman’s counterclaims.

  • Jury trial had been slated to begin Nov. 1 in Wilmington, Del. Judge Joseph F. Bataillon had postponed the trial in late June, days before ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.